Mycosis Fungoides and Sezary Syndrome — Trials

Mycosis Fungoides and Sezary Syndrome — Trials · CancerIndex

Clinical trials

Registered studies

148 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 32
Recruiting: 15
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 44.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00748319	Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma(KIR)	completed	N/A	495	Assistance Publique - Hôpitaux de ParisOTHER	1	Aug 22, 2012	clinicaltrials
NCT00535470	An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides	completed	Phase 2	100	Yaupon TherapeuticsINDUSTRY	1	Aug 9, 2012